Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 09, 2023

SELL
$9.59 - $11.35 $709 - $839
-74 Reduced 0.68%
10,768 $106,000
Q2 2023

Aug 10, 2023

BUY
$9.02 - $10.29 $748 - $854
83 Added 0.77%
10,842 $108,000
Q1 2023

May 02, 2023

BUY
$9.2 - $12.26 $377 - $502
41 Added 0.38%
10,759 $103,000
Q4 2022

Feb 07, 2023

SELL
$8.72 - $11.56 $9,382 - $12,438
-1,076 Reduced 9.12%
10,718 $119,000
Q3 2022

Oct 28, 2022

BUY
$8.48 - $11.13 $805 - $1,057
95 Added 0.81%
11,794 $100,000
Q2 2022

Jul 19, 2022

BUY
$9.95 - $12.27 $815 - $1,006
82 Added 0.71%
11,699 $122,000
Q1 2022

Apr 19, 2022

BUY
$9.81 - $15.4 $804 - $1,262
82 Added 0.71%
11,617 $126,000
Q2 2021

Jul 28, 2021

SELL
$12.97 - $16.15 $18,793 - $23,401
-1,449 Reduced 11.16%
11,535 $165,000
Q1 2021

May 05, 2021

SELL
$13.59 - $18.54 $584 - $797
-43 Reduced 0.33%
12,984 $181,000
Q4 2020

Jan 27, 2021

BUY
$14.3 - $18.74 $186,286 - $244,125
13,027 New
13,027 $244,000

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $9.25B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Karpas Strategies, LLC Portfolio

Follow Karpas Strategies, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Karpas Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Karpas Strategies, LLC with notifications on news.